1.
Ma L, Chen Z, Huang da W, Kutty G, Ishihara M, Wang H, Abouelleil A, Bishop L, Davey
E, Deng R et al: Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life
exclusively in mammalian hosts. Nature communications 2016, 7:10740.
2.
Ma L, Cisse OH, Kovacs JA: A Molecular Window into the Biology and Epidemiology of Pneumocystis spp. Clinical microbiology reviews 2018, 31(3).
3.
Asai N, Aoshima M, Ohkuni Y, Kobayashi H, Matsunuma R, Nakashima K, Katsurada N, Nakano
H, Otsuka Y, Kawamura Y et al: A successful diagnostic case of Pneumocystis pneumonia by the loop-mediated isothermal
amplification method in a patient with dermatomyositis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2012, 18(6):965-969.
4.
Omer O, Cohen P, Neong SF, Smith GV: Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A
preventable problem? Frontline gastroenterology 2016, 7(3):222-226.
5.
Wang DD, Zheng MQ, Zhang N, An CL: Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary
diseases in the People's Republic of China. International journal of chronic obstructive pulmonary disease 2015, 10:2079-2085.
6.
Wieruszewski PM, Barreto JN, Frazee E, Daniels CE, Tosh PK, Dierkhising RA, Mara KC,
Limper AH: Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated
With Better Outcome. Chest 2018, 154(3):636-644.
7.
Ye WL, Tang N, Wen YB, Li H, Li MX, Du B, Li XM: Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii
pneumonia in immunosuppressed patients with non-transplant glomerular disease. International urology and nephrology 2016, 48(11):1863-1871.
8.
Morris A, Norris KA: Colonization by Pneumocystis jirovecii and its role in disease. Clinical microbiology reviews 2012, 25(2):297-317.
9.
Khalife S, Aliouat EM, Aliouat-Denis CM, Gantois N, Devos P, Mallat H, Dei-Cas E,
Dabboussi F, Hamze M, Frealle E: First data on Pneumocystis jirovecii colonization in patients with respiratory diseases
in North Lebanon. New microbes and new infections 2015, 6:11-14.
10.
Ozkoc S, Bayram Delibas S: [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically
immunosuppressed and immunocompetent patients]. Mikrobiyoloji bulteni 2015, 49(2):221-230.
11.
Vera C, Aguilar YA, Velez LA, Rueda ZV: High transient colonization by Pneumocystis jirovecii between mothers and newborn. European journal of pediatrics 2017, 176(12):1619-1627.
12.
Danesi P, Ravagnan S, Johnson LR, Furlanello T, Milani A, Martin P, Boyd S, Best M,
Galgut B, Irwin P et al: Molecular diagnosis of Pneumocystis pneumonia in dogs. Medical mycology 2017, 55(8):828-842.
13.
Fauchier T, Hasseine L, Gari-Toussaint M, Casanova V, Marty PM, Pomares C: Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization
and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients. Journal of clinical microbiology 2016, 54(6):1487-1495.
14.
Khodadadi H, Mirhendi H, Mohebali M, Kordbacheh P, Zarrinfar H, Makimura K: Pneumocystis jirovecii Colonization in Non-HIV-Infected Patients Based on Nested-PCR
Detection in Bronchoalveolar Lavage Samples. Iranian journal of public health 2013, 42(3):298-305.
15.
Maillet M, Maubon D, Brion JP, Francois P, Molina L, Stahl JP, Epaulard O, Bosseray
A, Pavese P: Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj
colonization in immunocompromised patients. European journal of clinical microbiology & infectious diseases : official publication
of the European Society of Clinical Microbiology 2014, 33(3):331-336.
16.
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T: Loop-mediated isothermal amplification of DNA. Nucleic acids research 2000, 28(12):E63.
17.
Oscorbin IP, Belousova EA, Zakabunin AI, Boyarskikh UA, Filipenko ML: Comparison of fluorescent intercalating dyes for quantitative loop-mediated isothermal
amplification (qLAMP). BioTechniques 2016, 61(1):20-25.
18.
Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, Perez-Lozano
MJ, Varela JM, Calderon EJ: Pneumocystis jirovecii in general population. Emerging infectious diseases 2005, 11(2):245-250.
19.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR,
Chen R, Decramer M, Fabbri LM et al: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive
Lung Disease 2017 Report: GOLD Executive Summary. Archivos de bronconeumologia 2017, 53(3):128-149.
20.
Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk
DD, Denberg T, Schunemann H, Wedzicha W et al: Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical
practice guideline update from the American College of Physicians, American College
of Chest Physicians, American Thoracic Society, and European Respiratory Society. Annals of internal medicine 2011, 155(3):179-191.
21.
Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, Skowasch D, Park
JS, Poonyagariyagorn HK, Wuyts W et al: Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing
interstitial lung diseases. European respiratory review : an official journal of the European Respiratory Society
2018, 27(150).
22.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF,
Flaherty KR, Lasky JA et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based
guidelines for diagnosis and management. American journal of respiratory and critical care medicine 2011, 183(6):788-824.
23.
Nicolau DP, Sutherland C, Winget D, Baughman RP: Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750
mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis. Pulmonary pharmacology & therapeutics 2012, 25(1):94-98.
24.
Dodd JD, Lavelle LP, Fabre A, Brady D: Imaging in cystic fibrosis and non-cystic fibrosis bronchiectasis. Seminars in respiratory and critical care medicine 2015, 36(2):194-206.
25.
Smith MP: Diagnosis and management of bronchiectasis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
2017, 189(24):E828-E835.
26.
Wasche A, Schreiber J: [Pathophysiology, diagnosis and treatment of asthma: focusing on a chronic disease]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 2016, 51(6):392-399.
27.
Vo P, Kharasch VS: Respiratory failure. Pediatrics in review 2014, 35(11):476-484; quiz 485-476.
28.
Rojas P, Friaza V, Garcia E, de la Horra C, Vargas SL, Calderon EJ, Pavon A: Early Acquisition of Pneumocystis jirovecii Colonization and Potential Association
With Respiratory Distress Syndrome in Preterm Newborn Infants. Clinical infectious diseases : an official publication of the Infectious Diseases
Society of America 2017, 65(6):976-981.
29.
Ozkoc S, Bayram Delibas S, Erbaycu AE, Erguden C, Akisu C: [Investigation of Pneumocystis jirovecii colonization in patients with pulmonary diseases]. Turkiye parazitolojii dergisi 2014, 38(4):214-219.
30.
Eischeid AC: SYTO dyes and EvaGreen outperform SYBR Green in real-time PCR. BMC research notes 2011, 4:263.
31.
Mekinian A, Durand-Joly I, Hatron PY, Moranne O, Denis G, Dei-Cas E, Morell-Dubois
S, Lambert M, Launay D, Delhaes L et al: Pneumocystis jirovecii colonization in patients with systemic autoimmune diseases:
prevalence, risk factors of colonization and outcome. Rheumatology 2011, 50(3):569-577.
32.
Matsumura Y, Ito Y, Iinuma Y, Yasuma K, Yamamoto M, Matsushima A, Nagao M, Takakura
S, Ichiyama S: Quantitative real-time PCR and the (1-->3)-beta-D-glucan assay for differentiation
between Pneumocystis jirovecii pneumonia and colonization. Clinical microbiology and infection : the official publication of the European Society
of Clinical Microbiology and Infectious Diseases 2012, 18(6):591-597.
33.
Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura
K, Kumagai S: Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia,
invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. Journal of clinical microbiology 2012, 50(1):7-15.
34.
Tasaka S, Kobayashi S, Yagi K, Asami T, Namkoong H, Yamasawa W, Ishii M, Hasegawa
N, Betsuyaku T: Serum (1 --> 3) beta-D-glucan assay for discrimination between Pneumocystis jirovecii
pneumonia and colonization. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2014, 20(11):678-681.
35.
Kling HM, Shipley TW, Patil S, Morris A, Norris KA: Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected
cynomolgus macaques. The Journal of infectious diseases 2009, 199(1):89-96.
36.
Mansharamani NG, Balachandran D, Vernovsky I, Garland R, Koziel H: Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in
immunocompromised patients without HIV infection. Chest 2000, 118(3):712-720.
37.
Overgaard UM, Helweg-Larsen J: Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective
study 2002-2004. Scandinavian journal of infectious diseases 2007, 39(6-7):589-595.
38.
Chew LC, Maceda-Galang LM, Tan YK, Chakraborty B, Thumboo J: Pneumocystis jirovecii pneumonia in patients with autoimmune disease on high-dose
glucocorticoid. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal
diseases 2015, 21(2):72-75.
39.
Park JW, Curtis JR, Moon J, Song YW, Kim S, Lee EB: Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in
patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids. Annals of the rheumatic diseases 2018, 77(5):644-649.
40.
Korkmaz Ekren P, Toreyin ZN, Nahid P, Doskaya M, Caner A, Turgay N, Zeytinoglu A,
Toz S, Bacakoglu F, Guruz Y et al: The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and
mortality in immunocompromised non-HIV patients. The clinical respiratory journal 2018, 12(11):2590-2597.
41.
Mamoudou S, Bellaud G, Ana C, Gilles P: [Lung co-infection by Pneumocystis jirovecii and Pseudomonas aeruginosa in AIDS: report
of two cases]. The Pan African medical journal 2015, 21:95.
42.
Markantonatou AM, Ioakimidou A, Arvaniti K, Manou E, Papadopoulos V, Kiriklidou P,
Samaras K, Kioumi A, Vyzantiadis TA: Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV
patients: A report of two cases and literature review. Mycoses 2017, 60(10):626-633.